Pancreatic Cancer Market Size & Share, by Type (Chemotherapy, Targeted Therapy); Affected Area (Exocrine, Endocrine); End-user (Clinics, Hospitals) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5299
  • Published Date: Oct 09, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2024-2036

Pancreatic Cancer Market size is estimated to surpass USD 36 Billion by the end of 2036, growing at a CAGR of 18% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of the pancreatic cancer was over USD 6 Billion. The growth of the market can be attributed to the rising prevalence of cancer cases among people across the world. It is expected that there will be nearly 40 million new cancer cases across the globe by 2040, according to the Pan American Health Organization.

The changing lifestyle habits and adoption of alcohol are estimated to boost market growth across the world. The increasing prevalence of obesity is also estimated to drive market growth around the world. More than 1 billion population across the globe are suffering from obesity with over 600 million adults, 40 million children, and more than 300 million adolescents.

Pancreatic Cancer Market
Get more information on this report: Request Free Sample PDF

Pancreatic Cancer Sector: Growth Drivers and Challenges

Growth Drivers

  • Rising Geriatric Population Across the World with Reduced Immunity – The chances of developing cancer cells in the body can increase with the age of the person. As per the estimations in 2023, more than 1 in 6 people in America which is 80 million people are now the age 65 and above.
  • Growing Number of Research Projects- The increasing number of financially funded research projects by the National Cancer Institute to develop medications and treatments is projected to propel the market’s growth.
  • Increasing Incidence of Cancers related to the Digestive System and Stomach owing to Unhealthy Foods –Consumption of red meat, processed meat, and meals are high in saturated fats, alcohol, and fructose-containing foods and drinks may raise the chance of developing pancreatic cancer.


  • Side Effects of Radiation and Chemotherapy – The side effects of chemotherapy include pain, dizziness, fever, vomiting, and frequent bowel movement and the side effects of radiation therapy include diarrhea, shortness of breath, change in taste, and urinary and bladder problems. All these factors are estimated to be the reason for the hampering of market growth.
  • Rising Cost of Drug Development and Treatment
  • Stringent Government Regulatory Guidelines

Pancreatic Cancer Market: Key Insights

Base Year


Forecast Year



~ 18 %

Base Year Market Size (2023)

~ USD 6 Billion

Forecast Year Market Size (2036)

~ USD 36 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Pancreatic Cancer Segmentation

Type (Chemotherapy, Targeted Therapy)

The chemotherapy segment is estimated to account for 55% share of the global pancreatic cancer market in the year 2036. The increasing use of chemotherapy and targeted therapy for cancer cell isolation in tumor formation is estimated to propel the market segment growth as per the market analysis. The rising presence of competent practitioners and increasing medical facilities for providing chemotherapy across the world are expected to drive market segment growth in the coming years. More than 26% of people across the UK are estimated to have chemotherapy as the primary treatment for pancreatic cancer as of 2020.

Affected Area (Exocrine, Endocrine)

The exocrine segment is expected to hold 60% of the revenue share by 2036. The pancreas is mostly composed of exocrine cells compared to endocrine cells in the body is estimated to drive the market segment growth. The growth of the segment is attributed to the increasing prevalence of exocrine cancers. More than 90% of pancreatic cancers across the world are exocrine tumours as of estimations in 2022. Cancer in the ducts affects the exocrine cells of the pancreas causing exocrine cancer and is estimated to drive market growth across the world.

Our in-depth analysis of the global market includes the following segments:



  • Chemotherapy
  • Targeted Therapy
  • Hospital


                                               Affected Areas

  • Exocrine
  • Endocrine


                                                  End User

  • Hospitals
  • Clinics

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Pancreatic Cancer Industry - Regional Synopsis

North American Market Forecast

The pancreatic cancer market in the North America is projected to be the largest with a share of about 32% by the end of 2036. The growth of the market can be attributed majorly to the increasing adoption of new technologies for the treatment of cancer cases in the region. In addition, there has been a rise in the number of clinics providing chemotherapy in the countries such as the United States, that is further adding opportunities for the market’s growth in the region.

Asia Pacific Market Statistics

The Asia Pacific region is projected to hold around 28% share of the global pancreatic cancer market by 2036. The increasing number of diagnostic tests occurring in the region with a high prevalence rate is also driving the market growth. The rising pharmaceutical companies across the region with clinical trials to develop new drugs are estimated to hike the market growth in the Asia Pacific region.

Research Nester
Pancreatic Cancer Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating Pancreatic Cancer Landscape

    • Amgen Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
    • Novartis AG Pfizer Inc.
    •  Aduro Biotech Inc.
    • Clovis Oncology Inc.
    • NewLink Genetics Corp
    •  Infinity Pharmaceuticals, Inc.
    • Celgene Corporation

In the News

  • Amgen Inc.’s new drug targeting KRAS mutations was approved by the U.S. Food and Drug Administration. This is the first-ever therapy developed to treat KRAS cancers, which are often altered in the colon, lung, and pancreatic areas.
  • Novartis AG declared that US Food and Drug Administration granted the NIS793 with Orphan Drug Designation ODD along with standard chemotherapy care for the treatment of pancreatic cancer.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 5299
  • Published Date: Oct 09, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The major factors driving the market growth are the increasing geriatric population around the world and the rising prevalence of obesity.

The market size of pancreatic cancer treatment is anticipated to attain a CAGR of 18% over the forecast period, i.e., 2023-2036.

Lack of skilled professionals and side effects of chemo and radiotherapy are estimated to be the growth hindering factors for the market expansion

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

The major players in the market are Amgen Inc., F. Hoffman-La Roche AG, Novartis AG, Pfizer Inc., Aduro Biotech Inc., Clovis Oncology Inc., Threshold Pharmaceuticals Inc., NewLink Genetics Corp, Infinity Pharmaceuticals Inc., Celgene Corporation.
Pancreatic Cancer Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying